Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma

Showing 26 - 50 of 310
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (CG-806)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Phoenix, Arizona
  • +30 more
Mar 28, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)

Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • (no location specified)
Mar 28, 2022

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Chapel Hill, Houston (CAR.CD30 T cells)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • CAR.CD30 T cells
  • Chapel Hill, North Carolina
  • +2 more
Mar 16, 2022

Non-hodgkin's Lymphoma Trial in Beijing (Chiauranib, Chidamide)

Completed
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 7, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
Has Results
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Non-Hodgkin's Lymphoma Trial in China (single dose of CNCT19)

Recruiting
  • Non-Hodgkin's Lymphoma
  • single dose of CNCT19
  • Fuzhou, Fujian, China
  • +17 more
Feb 17, 2022

Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • CD19.CAR-CD28Z T Cells - dose escalation 2
  • CD19.CAR-CD28Z T Cells - dose escalation 1
  • Houston, Texas
  • +1 more
Feb 10, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • autologous CAR.CD30 EBV specific-CTLs
  • Houston, Texas
  • +1 more
Feb 4, 2022

Non-hodgkin's Lymphoma Trial in Langfang (CD19+22 CAR-T cells)

Recruiting
  • Non-hodgkin's Lymphoma
  • CD19+22 CAR-T cells
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 11, 2022

Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
  • +16 more
Dec 3, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Winston-Salem

Recruiting
  • Acute Myelogenous Leukemia
  • +9 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health
    Nov 23, 2021

    Acute Myeloid Leukemia, Non-hodgkin's Lymphoma, Multiple Myeloma Trial in Hangzhou (CD70 CAR T-cells)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • CD70 CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 26, 2021

    Non-Hodgkin's Lymphoma Trial in Stanford ([ 18F]F-AraG PET)

    Recruiting
    • Non-Hodgkin's Lymphoma
    • [ 18F]F-AraG PET
    • Stanford, California
      Stanford University, School of Medicine
    Oct 14, 2021

    Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 18, 2021

    Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in United States (hLL1-DOX (IMMU-115))

    Terminated
    • Non-Hodgkin's Lymphoma
    • Chronic Lymphocytic Leukemia
    • hLL1-DOX (IMMU-115)
    • Newark, Delaware
    • +5 more
    Oct 6, 2021

    Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)

    Terminated
    Has Results
    • Non-Hodgkin's Lymphoma
    • Berkeley, California
    • +8 more
    Sep 6, 2021

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

    Active, not recruiting
    • Hodgkin's Lymphoma
    • +8 more
    • Reduced intensity haplodentical stem cell transplant
    • Myeloablative haploidentical stem cell transplant
    • Birmingham, United Kingdom
    • +11 more
    Sep 27, 2021

    Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, B-cell Lymphoma Refractory Trial in Cologne,

    Active, not recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • +3 more
    • MB-CART20.1
    • Cologne, Germany
    • +1 more
    Sep 20, 2021

    Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • +7 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Sep 14, 2021

    Non-hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (IMMU-114)

    Terminated
    • Non-hodgkin's Lymphoma
    • +5 more
    • Newark, Delaware
    • +4 more
    Aug 12, 2021

    Non-Hodgkin's Lymphoma, Lymphoma, B-Cell Trial (radiolabeled epratuzumab)

    Completed
    • Non-Hodgkin's Lymphoma
    • Lymphoma, B-Cell
    • radiolabeled epratuzumab
    • (no location specified)
    Aug 12, 2021

    Non-Hodgkin's Lymphoma, Lymphoma, Diffuse, Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Trial in Lille, Lyon, Leicester

    Completed
    • Non-Hodgkin's Lymphoma
    • +2 more
    • Lille, Cedex, France
    • +2 more
    Aug 12, 2021

    Non-Hodgkin's Lymphoma Trial in New York, Philadelphia, Houston (hA20-humanized anti-CD20 antibody)

    Completed
    • Non-Hodgkin's Lymphoma
    • hA20-humanized anti-CD20 antibody
    • New York, New York
    • +2 more
    Aug 12, 2021

    Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia (ALL)
    • +4 more
    • Maywood, Illinois
    • +1 more
    Aug 1, 2021